02/26/2025
3:18 PM | Charles River Laboratories International (Issuer)
Girshick Birgit (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
3:36 PM | Charles River Laboratories International (Issuer)
LaPlume Joseph W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
3:38 PM | Charles River Laboratories International (Issuer)
Girshick Birgit (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
3:41 PM | Charles River Laboratories International (Issuer)
FOSTER JAMES C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
3:30 PM | Charles River Laboratories International (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/20/2025
11:36 AM | Charles River Laboratories International (Subject)
LaPlume Joseph W (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/19/2025
8:07 AM | Charles River Laboratories International (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/19/2025
6:19 AM | Charles River Laboratories International (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/03/2025
4:17 PM | Charles River Laboratories International (Issuer)
Pease Flavia (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
3:22 PM | Charles River Laboratories International (Issuer)
Girshick Birgit (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
3:25 PM | Charles River Laboratories International (Issuer)
Creamer Victoria L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for CRL and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Charles River Laboratories International and its competitors with MarketBeat's FREE daily newsletter. |
02/03/2025
3:27 PM | Charles River Laboratories International (Issuer)
Knell Michael Gunnar (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
7:04 AM | Charles River Laboratories International (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/13/2024
3:42 PM | Charles River Laboratories International (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2024
5:21 PM | Barbo William D (Reporting)
Charles River Laboratories International (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2024
4:31 PM | BlackRock, Inc. (Filed by)
Charles River Laboratories International (Subject)
| Form SC 13G/A | |
11/08/2024
9:52 AM | Charles River Laboratories International (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G | |
11/07/2024
3:23 PM | Charles River Laboratories International (Subject)
WALLMAN RICHARD F (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/06/2024
8:16 AM | Charles River Laboratories International (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2024
6:21 AM | Charles River Laboratories International (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/22/2024
2:24 PM | BlackRock, Inc. (Filed by)
Charles River Laboratories International (Subject)
| Form SC 13G/A | |
08/13/2024
3:17 PM | Charles River Laboratories International (Issuer)
FOSTER JAMES C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
3:13 PM | Charles River Laboratories International (Issuer)
LaPlume Joseph W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2024
12:34 PM | Charles River Laboratories International (Subject)
LaPlume Joseph W (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/07/2024
8:15 AM | Charles River Laboratories International (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/07/2024
6:21 AM | Charles River Laboratories International (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/04/2024
3:46 PM | Charles River Laboratories International (Issuer)
LaPlume Joseph W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
3:17 PM | Charles River Laboratories International (Issuer)
Pease Flavia (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
3:37 PM | Charles River Laboratories International (Issuer)
LaPlume Joseph W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2024
7:05 PM | Barbo William D (Reporting)
Charles River Laboratories International (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2024
7:18 PM | Charles River Laboratories International (Issuer)
Parisotto Shannon M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2024
6:56 PM | Charles River Laboratories International (Issuer)
Pease Flavia (Reporting)
| Form 4/A | |
05/30/2024
7:02 PM | Charles River Laboratories International (Issuer)
Creamer Victoria L (Reporting)
| Form 4/A | |
05/30/2024
6:47 PM | Barbo William D (Reporting)
Charles River Laboratories International (Issuer)
| Form 4/A | |
05/30/2024
5:58 PM | Charles River Laboratories International (Issuer)
FOSTER JAMES C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
4:51 PM | Charles River Laboratories International (Issuer)
Knell Michael Gunnar (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
4:46 PM | Charles River Laboratories International (Issuer)
Girshick Birgit (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
4:48 PM | Charles River Laboratories International (Issuer)
Creamer Victoria L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
4:34 PM | Charles River Laboratories International (Issuer)
Knell Michael Gunnar (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
4:38 PM | Charles River Laboratories International (Issuer)
Pease Flavia (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
4:08 PM | Charles River Laboratories International (Issuer)
Creamer Victoria L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Your Wealth is Under Attack (Ad) Please don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your free gift, and see how Trump's victory could spark major gains for gold. Click here now to see how to stop them in their tracks! |
05/29/2024
4:10 PM | Charles River Laboratories International (Issuer)
Knell Michael Gunnar (Reporting)
| Form 4/A | |
05/29/2024
3:05 PM | Charles River Laboratories International (Filer)
| Form SD
Specialized Disclosure Report | |
05/28/2024
4:42 PM | Barbo William D (Reporting)
Charles River Laboratories International (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
4:25 PM | Charles River Laboratories International (Issuer)
Girshick Birgit (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
4:29 PM | Charles River Laboratories International (Issuer)
LaPlume Joseph W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
4:32 PM | Charles River Laboratories International (Issuer)
Parisotto Shannon M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
3:35 PM | Charles River Laboratories International (Issuer)
MASSARO GEORGE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2024
6:24 PM | Andrews Nancy C (Reporting)
Charles River Laboratories International (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2024
6:30 PM | Charles River Laboratories International (Issuer)
WILSON VIRGINIA M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2024
4:47 PM | Charles River Laboratories International (Issuer)
Thompson Craig B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2024
4:52 PM | Charles River Laboratories International (Issuer)
MACKAY MARTIN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2024
4:38 PM | BERTOLINI ROBERT J (Reporting)
Charles River Laboratories International (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2024
4:42 PM | Charles River Laboratories International (Issuer)
WALLMAN RICHARD F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2024
4:27 PM | Charles River Laboratories International (Issuer)
MASSARO GEORGE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2024
4:30 PM | Charles River Laboratories International (Issuer)
Llado George Sr. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2024
4:34 PM | Charles River Laboratories International (Issuer)
Kemps-Polanco Reshema (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2024
3:49 PM | Charles River Laboratories International (Issuer)
LaPlume Joseph W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2024
10:30 AM | Charles River Laboratories International (Subject)
LaPlume Joseph W (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/09/2024
3:20 PM | Charles River Laboratories International (Filer)
| Form S-3ASR | |
05/09/2024
8:17 AM | Charles River Laboratories International (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2024
6:31 AM | Charles River Laboratories International (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/24/2024
6:30 AM | Charles River Laboratories International (Filer)
| Form DEFA14A | |
03/29/2024
7:00 AM | Charles River Laboratories International (Filer)
| Form DEF 14A | |
03/29/2024
7:01 AM | Charles River Laboratories International (Filer)
| Form ARS | |
03/25/2024
5:48 PM | Barbo William D (Reporting)
Charles River Laboratories International (Issuer)
| Form 4/A | |
03/25/2024
5:52 PM | Charles River Laboratories International (Issuer)
Parisotto Shannon M (Reporting)
| Form 4/A | |
03/25/2024
5:58 PM | Charles River Laboratories International (Issuer)
FOSTER JAMES C (Reporting)
| Form 4/A | |
03/25/2024
6:00 PM | Charles River Laboratories International (Issuer)
Creamer Victoria L (Reporting)
| Form 4/A | |
03/25/2024
4:49 PM | Charles River Laboratories International (Issuer)
Knell Michael Gunnar (Reporting)
| Form 4/A | |
03/25/2024
4:52 PM | Charles River Laboratories International (Issuer)
Girshick Birgit (Reporting)
| Form 4/A | |
03/25/2024
4:55 PM | Charles River Laboratories International (Issuer)
LaPlume Joseph W (Reporting)
| Form 4/A | |
Buy CRL Stock Free CRL Stock Alerts